Exhibit 99.1



                  Aspyra Reports Results of Operations for the
                       First Quarter Ended March 31, 2006


    CALABASAS, Calif.--(BUSINESS WIRE)--May 22, 2006--Aspyra, Inc.
(AMEX:APY), a provider of clinical and diagnostic information systems
for the healthcare industry, today reported its results of operations
for the first quarter ended March 31, 2006.
    Sales were $2,702,075 for the first quarter compared with sales of
$1,825,288 for the comparable quarter ended March 31, 2005. The
Company incurred a net loss of $1,313,718, or basic and diluted loss
per share of $.15 for the first quarter ended March 31, 2006, compared
with a net loss of $186,964, or basic and diluted loss per share of
$.06 for the comparable quarter ended March 31, 2005. Basic and
diluted shares outstanding for each period were 8,489,400 and
3,353,900, respectively.
    Steven M. Besbeck stated, "The operating losses incurred by the
Company during the three-month period ended March 31, 2006, were
primarily a result of two factors. First, the Company experienced
delays related to implementation of systems, which prevented it from
recognizing revenue on many of its sales, which increased the
Company's deferred revenue as of March 31, 2006. Only a fraction of
the sales booked in the quarter ended March 31, 2006, were actually
recognized as revenue in that quarter. The backlog of deferred revenue
associated with such sales will be recognized in future periods.
Second, the Company is engaged in executing integration and
restructuring related to the merged businesses of Creative Computer
Applications and StorCOMM, Inc. and incurred certain costs associated
with such activities, which were only partially offset by reductions
in redundant personnel and other expenses during the quarter ended
March 31, 2006. The Company expects to achieve synergies and cost
reductions in its business as it completes further integration and
restructuring in the next two fiscal quarters."

    Aspyra Inc. is a global provider of clinical and diagnostic
information solutions for the healthcare industry. It has accumulated
over 35 years of industry experience, specializing in enterprise-wide
systems for hospitals, multi-specialty clinics, clinical laboratories,
imaging departments and centers, orthopedic environments and
pharmacies. Aspyra's highly scalable products may be installed as
standalone or integrated to provide a single-vendor solution. For more
information on Aspyra, its products and services, visit
www.aspyra.com.

    Safe Harbor Statement

    This press release includes forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995,
including statements related to anticipated revenues, expenses,
earnings, operating cash flows, the outlook for Aspyra's markets and
the demand for its products. Forward-looking statements are not
guarantees of future performance and are inherently subject to
uncertainties and other factors which could cause actual results to
differ materially from the forward-looking statement. Such statements
are based upon, among other things, assumptions made by, and
information currently available to, management as of today May 22,
2006, including management's own knowledge and assessment of the
Company's industry and competition. Factors that could cause Aspyra's
actual results to differ materially from these forward-looking
statements include among others: whether the combined company will
realize the potential benefits of the merger; the competitive
environment; unexpected technical and marketing difficulties inherent
in major product development efforts; the potential need for changes
in our long-term strategy in response to future developments; future
advances in clinical information technology and procedures, as well as
potential changes in government regulations and healthcare policies;
and rapid technological change in the microelectronics and software
industries. The Company refers interested persons to its most recent
Annual Report on Form 10-KSB and its other SEC filings for a
description of additional uncertainties and factors, which may affect
forward-looking statements. The Company assumes no duty to update its
forward-looking statements.


    CONTACT: Aspyra, Inc.
             Steven M. Besbeck, President and CEO, 818-880-6700, x252
             or
             The Wall Street Group, Inc.
             Ron Stabiner, 212-888-4848